Real‐world evidence concerning clinical and economic outcomes of switching to insulin glargine 300 units/mL vs other basal insulins in patients with type 2 diabetes using basal insulin

This retrospective cohort study compared real‐world clinical and healthcare‐resource utilization (HCRU) data in patients with type 2 diabetes using basal insulin (BI) who switched to insulin glargine 300 units/mL (Gla‐300) or another BI. Data from the Predictive Health Intelligence Environment datab...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Diabetes Obes Metab
Autores principales: Zhou, Fang Liz, Ye, Fen, Berhanu, Paulos, Gupta, Vineet E., Gupta, Rishab A., Sung, Jennifer, Westerbacka, Jukka, Bailey, Timothy S., Blonde, Lawrence
Formato: Artigo
Lenguaje:Inglês
Publicado: Blackwell Publishing Ltd 2018
Materias:
Brief Reports
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC5947830/
https://ncbi.nlm.nih.gov/pubmed/29272064
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/dom.13199
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares